Article Details
Retrieved on: 2024-05-07 18:10:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs.
Article found on: efecomunica.efe.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here